Barure Ramdas, Shanthaiah Dhananjaya Melkunte, Atluri Sridevi, Channabasappa Shivaprasad, Kolla Gautam, Reddy S L Sagar, Sarathi Vijaya
Department of Endocrinology, Vydehi Institute of Medical Sciences and Research Center, Bengaluru, Karnataka, India.
Department of Endocrinology, Sapthagiri Institute of Medical Sciences and Research Center, Bengaluru, Karnataka, India.
Indian J Endocrinol Metab. 2022 Jul-Aug;26(4):372-375. doi: 10.4103/ijem.ijem_155_22. Epub 2022 Sep 20.
The American Diabetes Association recommends statin therapy for young type 2 diabetes mellitus (T2DM) adults only if one additional cardiovascular (CV) risk factor coexists. The data regarding CV risk factors in young Indian T2DM adults is limited. Hence, we assessed the prevalence of CV risk factors in young adults with T2DM from eastern India.
In this cross-sectional study, diabetic medical health check records of eastern-Indian T2DM patients performed between March 2018 and March 2019 were retrospectively reviewed and the relevant data of T2DM patients (n = 3564) including CV risk factors [serum LDL-cholesterol of ≥100 mg/dL, hypertension (>140/90 mmHg), smoking, chronic kidney disease (eGFR of <60 ml/min), microalbumin to creatinine ratio of ≥30 mg/mg, and obesity/overweight (body mass index ≥23 kg/m)] were analysed.
There were 3280 T2DM patients from eastern India and 679 (20.7%) were ≤40 years of age. Overweight/obesity (74.3%) and serum LDL-cholesterol of ≥100 mg/dL (69.2%) were the two most common additional CV risk factors. At least one additional CV risk factor was present in 576 (95.36%) patients, whereas at least two additional CV risk factors were present in 409 (67.7%) patients. At least one non-obesity/overweight CV risk factor was present in 472 (78.1%) patients.
The study demonstrates a high prevalence of additional CV risk factors in young eastern-Indian adults with T2DM. Hence, there is a need for an intensive approach to managing the CV risk factors in young Indian adults with T2DM.
美国糖尿病协会建议,仅当存在一种额外的心血管(CV)危险因素时,才对年轻的2型糖尿病(T2DM)成人进行他汀类药物治疗。关于印度年轻T2DM成人CV危险因素的数据有限。因此,我们评估了印度东部年轻T2DM成人中CV危险因素的患病率。
在这项横断面研究中,回顾性分析了2018年3月至2019年3月期间印度东部T2DM患者的糖尿病医疗健康检查记录,并分析了T2DM患者(n = 3564)的相关数据,包括CV危险因素[血清低密度脂蛋白胆固醇≥100 mg/dL、高血压(>140/90 mmHg)、吸烟、慢性肾脏病(估算肾小球滤过率<60 ml/min)、微量白蛋白与肌酐比值≥30 mg/mg以及肥胖/超重(体重指数≥23 kg/m²)]。
有3280名来自印度东部的T2DM患者,其中679名(20.7%)年龄≤40岁。超重/肥胖(74.3%)和血清低密度脂蛋白胆固醇≥100 mg/dL(69.2%)是两个最常见的额外CV危险因素。576名(95.36%)患者存在至少一种额外的CV危险因素,而409名(67.7%)患者存在至少两种额外的CV危险因素。472名(78.1%)患者存在至少一种非肥胖/超重的CV危险因素。
该研究表明,印度东部年轻的T2DM成人中额外CV危险因素的患病率很高。因此,有必要采取强化措施来管理印度年轻T2DM成人的CV危险因素。